Skip to main content
Image
CKM logo reversed
CKM
Cardiology Vascular Medical Education
Register for free Log in
Cardiovascular • Kidney • Metabolic
Lifelong learning for healthcare professionals
CVRM banner
CVRM banner

Home

About

About Us Advisory Board

Topics

View AllChronic Kidney DiseaseDiabetesCardiovascular Co-morbiditiesMetabolic Dysfunction-associated Fatty Liver Disease (MAFLD)Obesity

Content type

Videos Articles Broadcasts Podcasts News

Faculty

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z View All

Events

Upcoming Events Radcliffe Events All Events

Resource Hubs

Inflammatory Risk in CVD Rise of CVRM
  • Content for healthcare professionals only
Image
CKM logo
Register for free Log in
Back to Main Menu

View all platforms

Cardiology Vascular CKM Medical Education
  • Content for healthcare professionals only

Breadcrumb

  • Home /
  • News Index

Latest News

Tirzepatide Linked to Lower Cardiorenal Events vs Dulaglutide
Written by: Radcliffe CKM
Tirzepatide Linked to Lower Cardiorenal Events vs Dulaglutide
27 April 2026
SOUL: Oral Semaglutide Improves CV Risk Factors in T2D
Written by: Radcliffe CKM
SOUL: Oral Semaglutide Improves CV Risk Factors in T2D
22 April 2026
hsCRP Improves CV Risk Prediction in Primary Prevention
Written by: Radcliffe CVRM
hsCRP Improves CV Risk Prediction in Primary Prevention
15 April 2026
Ez-PAVE: Lower LDL-C Target Reduces CV Events
Written by: Radcliffe CVRM
Ez-PAVE: Lower LDL-C Target Reduces CV Events
15 April 2026
SOUL: Oral Semaglutide Aids CV Risk in T2D
Written by: Radcliffe CVRM
SOUL: Oral Semaglutide Aids CV Risk in T2D
28 March 2026
GLP-1RAs Cut Cardiorenal Events in Type 1 Diabetes
Written by: Radcliffe CVRM
GLP-1RAs Cut Cardiorenal Events in Type 1 Diabetes
27 March 2026
Aldosteronism Linked to AF and Stroke Risk in Older Adults
Written by: Radcliffe CVRM
Aldosteronism Linked to AF and Stroke Risk in Older Adults
19 March 2026
Semaglutide May Aid Vascular Repair in High-Risk Patients
Written by: Radcliffe CVRM
Semaglutide May Aid Vascular Repair in High-Risk Patients
19 March 2026
Higher ARR Linked to AF and Stroke Risk in Older Adults
Written by: Radcliffe CVRM
Higher ARR Linked to AF and Stroke Risk in Older Adults
12 March 2026
Oral Orforglipron Superior to Semaglutide for T2D Control
Written by: Radcliffe CVRM
Oral Orforglipron Superior to Semaglutide for T2D Control
10 March 2026
  • Load More

External news

Written by: Cardiovascular Business
Scrapped CGM sensors stolen, sold to patients—Dexcom pledges to hold thieves accountable
29 May 2026
Written by: Medscape
Discussing a Diagnosis of Alzheimer’s Disease With Patients
29 May 2026
Written by: Medscape
May 29 2026 This Week in Cardiology
29 May 2026
Written by: Cardiovascular Business
FDA shares another warning about Impella heart pumps after death
29 May 2026
Written by: Cardiovascular Business
FDA sees potential in new AI software for monitoring heart failure patients
29 May 2026
Written by: Cardiovascular Business
SAPT after TAVR linked to key benefits over DAPT, new data confirm
29 May 2026
Written by: Medscape
Higher Abdominal Fat Linked to Faster Biological Aging
29 May 2026
Written by: Medscape
Nighttime BP Measured Using Wrist Device Reveals Heart Risks
29 May 2026
Written by: Medscape
Does Obesity Drive Related Conditions in Older Adults?
29 May 2026
Written by: Medscape
Which Patients With Early HCC Should Undergo Resection?
29 May 2026
  • Load More

Footer Menu 1

  • About Us
  • Our team
  • Privacy
  • Terms & Conditions
  • Contact Us
  • Radcliffe Group
  • Radcliffe Events

Footer Menu 2

  • Authors A-Z
  • Image gallery
  • Industry Partners
  • Media Partners
  • Promotional Opportunities
  • Education by Breas

Quick Links 1

  • Arrhythmia and Electrophysiology Review
  • Cardiac Failure Review
  • European Cardiology Review
  • Interventional Cardiology
  • Journal of Asian Pacific Society of Cardiology
  • US Cardiology Review

Quick Links 2

  • Arrhythmia Academy
  • Heart Failure Academy
  • Transcatheter Academy
Register for FREE
CKM Logo

Copyright® 2026 Radcliffe Medical Media. All rights reserved.

Published content on this site is for information purposes and is not a substitute for professional medical advice. Where views/opinions are expressed, they are those of the author(s) and not of Radcliffe Medical Media.

Radcliffe Cardiology is part of Radcliffe Medical Media, an independent publisher and the Radcliffe Group Ltd. It is not affiliated with or is an agent of, the Oxford Heart Centre, the John Radcliffe Hospital or the Oxford University Hospitals NHS Foundation Trust group.